What is CONRAY 400 used for?

CONRAY 400 is an FDA-approved medication. See full prescribing information for approved uses.

Is CONRAY 400 FDA approved?

Yes, CONRAY 400 is FDA approved (first approved 1963-09-30) and manufactured by MALLINCKRODT.

Who makes CONRAY 400?

CONRAY 400 is manufactured by MALLINCKRODT.

Data updated: Mar 10, 2026

CONRAY 400

IOTHALAMATE SODIUM

Approved 1963-09-30

Jump to: Indications Approvals Trials Competitors Safety Patents

Indications

Phase 3 Trials

Years on Market

Details

Status: Discontinued
First Approved: 1963-09-30
Routes: INJECTION
Dosage Forms: INJECTABLE

Companies

MALLINCKRODT

Active Ingredient: IOTHALAMATE SODIUM

CONRAY 400 Approval History

Loading approval history...

What CONRAY 400 Treats

2 FDA approvals

Originally approved for its first indication in 1963 . Covers 2 distinct patient populations.

Other (2)

🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

⭐

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

📊

Trial Timeline

ClinicalTrials.gov ↗ Pro

Full development history with FDA approval milestones

Understanding FDA Approval Types

Count	Type	What it means
-	ORIG	Original approval - drug first enters market
-	SUPPL - Efficacy	New indication (new disease/condition approved)
-	SUPPL - Labeling	Label text changes (warnings, dosing updates)
-	SUPPL - Manufacturing	Production changes (new facility)
-	SUPPL - Chemistry	Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CONRAY 400 FDA Label Details

Pro

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

FDA Approval: NDA014295 → Patents: FDA Orange Book → Trials: ClinicalTrials.gov →

Data sourced from official FDA and NIH databases. Click links to verify on original sources.